Bulk Manufacturer of Controlled Substances Application: Veranova, L.P., 39647 [2024-10084]
Download as PDF
<![CDATA[
39647
Federal Register / Vol. 89, No. 91 / Thursday, May 9, 2024 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 8, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 8, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1367]
Bulk Manufacturer of Controlled
Substances Application: Veranova,
L.P.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Veranova, L.P. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
SUMMARY:
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 8, 2024,
Veranova, L.P., 2003 Nolte Drive, West
Deptford, New Jersey 08066–1727,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
ddrumheller on DSK120RN23PROD with NOTICES1
Gamma hydroxybutyric acid ..................................................................................................................................................
Marihuana ..............................................................................................................................................................................
Tetrahydrocannabinols ..........................................................................................................................................................
3,4-Methylenedioxymethamphetamine ..................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Dihydromorphine ...................................................................................................................................................................
Difenoxin ................................................................................................................................................................................
Fentanyl related-substances .................................................................................................................................................
Amphetamine .........................................................................................................................................................................
Methamphetamine .................................................................................................................................................................
Lisdexamfetamine ..................................................................................................................................................................
Methylphenidate ....................................................................................................................................................................
Nabilone .................................................................................................................................................................................
4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ..........................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) .......................................................................................................
Cocaine ..................................................................................................................................................................................
Codeine .................................................................................................................................................................................
Dihydrocodeine ......................................................................................................................................................................
Oxycodone .............................................................................................................................................................................
Hydromorphone .....................................................................................................................................................................
Diphenoxylate ........................................................................................................................................................................
Ecgonine ................................................................................................................................................................................
Hydrocodone .........................................................................................................................................................................
Levorphanol ...........................................................................................................................................................................
Meperidine .............................................................................................................................................................................
Methadone .............................................................................................................................................................................
Methadone intermediate ........................................................................................................................................................
Morphine ................................................................................................................................................................................
Thebaine ................................................................................................................................................................................
Opium tincture .......................................................................................................................................................................
Oxymorphone ........................................................................................................................................................................
Noroxymorphone ...................................................................................................................................................................
Alfentanil ................................................................................................................................................................................
Remifentanil ...........................................................................................................................................................................
Sufentanil ...............................................................................................................................................................................
Tapentadol .............................................................................................................................................................................
Fentanyl .................................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for use as internal
intermediates and for sale to its
customers. No other activities for these
2010
7360
7370
7405
7437
9145
9168
9850
1100
1105
1205
1724
7379
8333
8366
9041
9050
9120
9143
9150
9170
9180
9193
9220
9230
9250
9254
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
Schedule
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
drug codes are authorized for this
registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–10084 Filed 5–8–24; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:17 May 08, 2024
Jkt 262001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 89, Number 91 (Thursday, May 9, 2024)]
[Notices]
[Page 39647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10084]
[[Page 39647]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1367]
Bulk Manufacturer of Controlled Substances Application: Veranova,
L.P.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Veranova, L.P. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 8, 2024. Such persons may also file a written request for a
hearing on the application on or before July 8, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on April 8, 2024, Veranova, L.P., 2003 Nolte Drive, West
Deptford, New Jersey 08066-1727, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid.................. 2010 I
Marihuana.................................. 7360 I
Tetrahydrocannabinols...................... 7370 I
3,4-Methylenedioxymethamphetamine.......... 7405 I
Psilocybin................................. 7437 I
Dihydromorphine............................ 9145 I
Difenoxin.................................. 9168 I
Fentanyl related-substances................ 9850 I
Amphetamine................................ 1100 II
Methamphetamine............................ 1105 II
Lisdexamfetamine........................... 1205 II
Methylphenidate............................ 1724 II
Nabilone................................... 7379 II
4-Anilino-N-Phenethyl-4-Piperidine (ANPP).. 8333 II
Norfentanyl (N-phenyl-N-(piperidin-4-yl) 8366 II
propionamide).
Cocaine.................................... 9041 II
Codeine.................................... 9050 II
Dihydrocodeine............................. 9120 II
Oxycodone.................................. 9143 II
Hydromorphone.............................. 9150 II
Diphenoxylate.............................. 9170 II
Ecgonine................................... 9180 II
Hydrocodone................................ 9193 II
Levorphanol................................ 9220 II
Meperidine................................. 9230 II
Methadone.................................. 9250 II
Methadone intermediate..................... 9254 II
Morphine................................... 9300 II
Thebaine................................... 9333 II
Opium tincture............................. 9630 II
Oxymorphone................................ 9652 II
Noroxymorphone............................. 9668 II
Alfentanil................................. 9737 II
Remifentanil............................... 9739 II
Sufentanil................................. 9740 II
Tapentadol................................. 9780 II
Fentanyl................................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for use as internal intermediates and for sale to its
customers. No other activities for these drug codes are authorized for
this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-10084 Filed 5-8-24; 8:45 am]
BILLING CODE P
